Durable Anti-Vi IgG and IgA Antibody Responses in 15-Month-Old Children Vaccinated With Typhoid Conjugate Vaccine in Burkina Faso

We assessed anti-Vi IgG/IgA responses to typhoid conjugate vaccine (TCV) in children enrolled in a double-blind randomized controlled, phase 2 trial in Burkina Faso. Anti-Vi IgG seroconversion and anti-Vi IgA titers were higher in TCV than control recipients at 30–35 months post-vaccination. TCV ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouedraogo, Alphonse, Diarra, Amidou, Nébié, Issa, Barry, Nouhoun, Kabore, Jean Moise, Tiono, Alfred B, Datta, Shrimati, Liang, Yuanyuan, Mayo, Ifayet, Oshinsky, Jennifer J, Tracy, J Kathleen, Girmay, Tsion, Pasetti, Marcela F, Jamka, Leslie P, Neuzil, Kathleen M, Sirima, Sodiomon B, Laurens, Matthew B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533206/
https://www.ncbi.nlm.nih.gov/pubmed/37589596
http://dx.doi.org/10.1093/jpids/piad058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533206/
https://www.ncbi.nlm.nih.gov/pubmed/37589596
http://dx.doi.org/10.1093/jpids/piad058

Ejemplares similares